Equasens

Pre-Annual General Meeting Information • Jun 2, 2016

.

Villers-lès-Nancy, June 2, 2016 – 18h00 (CET)

PRESS RELEASE

Annual Ordinary General Meeting Preliminary Notice

PHARMAGEST INTERACTIVE hereby provides notice to shareholders of the annual ordinary and extraordinary general meeting to be held on Thursday, June 23, 2016 at 5.00 pm at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.

The agenda and draft resolutions have been published in the BALO legal gazette on May 16, 2016 (www.journalofficiel.gouv.fr ). The BALO notice can be reviewed on the website of the company (www.pharmagest.com, Investor Relations).

The convening notice to attend the meeting will be published in the BALO and in the legal gazette "Les Tablettes Lorraines" on June 6, 2016

Pursuant to article R225-73-1 of the French commercial code, PHARMAGEST INTERACTIVE has published the documents prescribed by this article on its website 21 days prior to the meeting. They are online since June 2, 2016.

The shareholders may obtain any further information by request to PHARMAGEST INTERACTIVE's headquarter located in VILLERS-LES-NANCY (54600).

About the PHARMAGEST Group:

The PHARMAGEST Group is the French leader in pharmacy information technology, with a 43.5% share of the market and over 800 employees. The strategy of the PHARMAGEST Group is based on a core business – innovating in information technology to improve healthcare – and on the development of two priority focuses: services and technologies for healthcare professionals, notably support for pharmacists in monitoring patient compliance; and technology for improving the efficacy of healthcare systems.

To roll out that strategy, the PHARMAGEST Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for laboratories, connected health devices and apps, and a sales financing marketplace. These businesses are divided into 4 Divisions: the Solutions for Pharmacy Division – Europe, the Solutions for Sanitary and Medico-Social Establishments Division, the Solutions for e-Health Division, and the FinTech Division.

Listed on Euronext Paris™ - Compartment B Indices: ENTERNEXT TECH 40, CAC ® SMALL and CAC ® All-Tradable by inclusion Eligible for the Long-Only Deferred Settlement Service (SRD) ISIN: FR0012882389 – Reuters: PHA.PA – Bloomberg: PMGI FP PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance SMEs (PEA-PME)

For all the latest news, go to www.pharmagest.com

CONTACTS

Analyst and Investor Relations: Chief Financial Officer: Jean-Yves SAMSON Tel. +33 (0)3 83 15 90 67 – jean-yves.samson@pharmagest.com

Press Relations: FIN'EXTENSO – Isabelle APRILE Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr